4.3 Article

Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction

Journal

CLINICAL RESPIRATORY JOURNAL
Volume 11, Issue 6, Pages 859-866

Publisher

WILEY
DOI: 10.1111/crj.12428

Keywords

COPD; extracellular matrix proteins; inflammatory biomarkers; left ventricular diastolic function; tenascin-C

Funding

  1. Societat Catalana de Pneumologia (SOCAP)
  2. Fundacio Catalana de Pneumologia (FUCAP)
  3. Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)

Ask authors/readers for more resources

BackgroundLeft ventricular diastolic dysfunction (LVDD) is a frequent condition in chronic obstructive pulmonary disease (COPD). Tenascin-C (Tn-C) and matrix metalloproteinase-9 (MMP-9) are extracellular matrix proteins associated with myocardial fibrosis and wall remodeling because of inflammation. ObjectiveTo determine whether the circulating levels of inflammatory markers, Tn-C and MMP-9 are associated with LVDD in COPD patients. MethodsForty-two severe stable COPD patients (648 years, 88% male, FEV1% 385.7) and a control group (n=11) were included. Pulmonary function tests and a Doppler echocardiography were performed on COPD patients. Baseline serum levels of C-reactive protein (CRP), leukocytes, fibrinogen, interleukins (IL) 6 and 8, Tn-C and MMP-9 were analyzed in all participants. ResultsCOPD patients were classified in two groups: LVDD (n=35) and non-LVDD (n=7). Serum levels of IL-6 and CRP were higher in the LVDD group compared to the non-LVDD group [median(IQR)] [3.46 pg/mL (2.36-4.74) vs 1.87 pg/mL (1.10-3.28), P=0.045] and [6.0 mg/L (3.0-13.0) vs 1.0 mg/L (1.0-2.3), P=0.001], respectively. The same trend was observed in the analysis adjusted by age and BMI, being significant for CRP (P=0.04). Circulating IL-6 was associated with the type of LVDD, being higher in the type-II (P=0.046). Obese patients with COPD-LVDD showed a higher level of inflammatory markers (P=0.021). Tn-C were significantly higher in patients with LVDD type-II compared to type-I [1422 ng/mL (826-1948) vs 781 ng/mL (640-1139), P=0.015], without differences in MMP-9. ConclusionsSevere COPD patients with LVDD showed a different inflammatory pattern, suggesting a link between low-grade inflammation and the presence of LVDD. In COPD, high levels of Tn-C are related to LVDD type-II.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Silicone Stent Versus Fully Covered Metallic Stent in Malignant Central Airway Stenosis

Rosa Maria Ortiz-Comino, Arturo Morales, Rosa Lopez-Lisbona, Noelia Cubero, Marta Diez-Ferrer, Cristian Tebe, Antoni Rosell

Summary: The study compared the efficacy and complications of a fully covered self-expandable metal stent (SEMS) and a silicone stent in treating malignant central airway obstruction. Both stents were found to be equally successful and safe, with complications such as mucus retention, granulation tissue, and migration. The incidence of complications increased over time to over 90% at 6 months for both types of stents.

ANNALS OF THORACIC SURGERY (2021)

Article Medicine, General & Internal

Non-retrieved inferior vena cava filters: causes and long-term follow-up

Jesus Ribas, Esther Alba, Yuliana Pascual-Gonzalez, Yolanda Ruiz, Adriana Iriarte, Jose Maria Mora-Lujan, Joana Valcarcel, Xavier Corbella, Salud Santos, Elena Escalante, Antoni Riera-Mestre

Summary: The main preventable cause of non-retrieval of temporary IVC filters was lack of planning / follow-up. In patients with indwelling filters, the main cause of death was cancer and extended anticoagulation was not associated with survival.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Letter Medicine, General & Internal

Role of bronchoscopy in critically ill patients with COVID-19 pneumonia

M. Diez-Ferrer, C. Martin-Cabeza, N. Cubero, J. Sabater-Riera, S. Santos, R. M. Lopez-Lisbona

REVISTA CLINICA ESPANOLA (2021)

Letter Respiratory System

Comparing Probe-Based Confocal Laser Endomicroscopy With Histology. Are We Looking at the Same Picture?

Marta Diez-Ferrer, Benjamin Torrejon-Escribano, Nuria Baixeras, Cristian Tebe, Noelia Cubero, Rosa Lopez-Lisbona, Jordi Dorca, Antoni Rosell

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

Article Multidisciplinary Sciences

Membrane particles from mesenchymal stromal cells reduce the expression of fibrotic markers on pulmonary cells

Ana Merino, Martin J. Hoogduijn, Maria Molina-Molina, Elena G. Arias-Salgado, Sander S. Korevaar, Carla C. Baan, Ana Montes-Worboys

Summary: The study shows that Membrane Particles (MP) derived from mesenchymal stromal cells (MSC) have anti-fibrotic effects by targeting lung cells and reducing the expression of fibrotic proteins without cytotoxic effects. These findings suggest that MP may serve as an alternative therapeutic approach to traditional MSC administration in treating idiopathic pulmonary fibrosis.

PLOS ONE (2021)

Article Critical Care Medicine

Lung Ultrasound Score to Predict Outcomes in COVID-19

Pere Trias-Sabria, Maria Molina-Molina, Samantha Aso, Marta Hernandez Argudo, Marta Diez-Ferrer, Joan Sabater, Jordi Dorca, Salud Santos, Guillermo Suarez-Cuartin

Summary: This study investigated the potential role of lung ultrasound score (LUS) in patients with COVID-19 and found that LUS >= 24 points could help identify patients at higher risk of ICU admission or death. LUS also showed significant correlations with clinical and laboratory markers of COVID-19 severity.

RESPIRATORY CARE (2021)

Letter Respiratory System

Forum COPD Working Group Consensus on the Diagnosis, Treatment and Follow-Up of COPD

Jose Luis Lopez-Campos, Myriam Calle Rubio, Jose Luis Izquierdo Alonso, Alberto Fernandez-Villar, Beatriz Abascal-Bolado, Bernardino Alcazar, Francisco Garcia-Rio, German Peces-Barba, Joan Serra Batlles, Jose Javier Martinez Garceran, Juan Antonio Riesco Miranda, Juan Marco Figueira-Goncalves, Juan Jose Soler-Cataluna, Mikel Temprano, Francisco Ortega Ruiz, Salud Santos Perez, Carlos Jose alvarez Martinez

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

Article Medicine, General & Internal

Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction

Lurdes Planas-Cerezales, Elena G. Arias-Salgado, Cristina Berastegui, Ana Montes-Worboys, Rafaela Gonzalez-Montelongo, Jose M. Lorenzo-Salazar, Vanesa Vicens-Zygmunt, Marta Garcia-Moyano, Jordi Dorca, Carlos Flores, Rosario Perona, Antonio Roman, Maria Molina-Molina

Summary: The study showed that fibrotic ILD patients with telomere dysfunction after lung transplantation have higher morbidity, require more medical interventions, but still have a high 1-year survival rate, leading to improved quality of life and withdrawal of oxygen therapy.

FRONTIERS IN MEDICINE (2021)

Article Respiratory System

Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe

Theodoros Karampitsakos, Paolo Spagnolo, Nesrin Mogulkoc, Wim A. Wuyts, Sara Tomassetti, Elisabeth Bendstrup, Maria Molina-Molina, Effrosyni D. Manali, Omer Selim Unat, Francesco Bonella, Nicolas Kahn, Lykourgos Kolilekas, Elisabetta Rosi, Leonardo Gori, Claudia Ravaglia, Venerino Poletti, Zoe Daniil, Thomas Skovhus Prior, Ilias C. Papanikolaou, Samantha Aso, Stavros Tryfon, Despoina Papakosta, Vasillios Tzilas, Elisabetta Balestro, Spyridon Papiris, Katerina Antoniou, Demosthenes Bouros, Athol Wells, Michael Kreuter, Argyris Tzouvelekis

Summary: This study aimed to create a large database for patients with idiopathic pulmonary fibrosis (IPF) and lung cancer in Europe. The results showed that 10.2% of IPF patients also had lung cancer, and IPF patients with lung cancer had a higher risk of all-cause mortality. Lung cancer patients who received antifibrotic treatment had lower all-cause mortality, and surgically treated IPF patients with operable lung cancer had lower all-cause mortality.

RESPIROLOGY (2023)

Article Environmental Sciences

Outcomes of COVID-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-Invasive Respiratory Therapy in a Sequential Protocol

Merce Gasa, Yolanda Ruiz-Albert, Ana Cordoba-Izquierdo, Mikel Sarasate, Ester Cuevas, Guillermo Suarez-Cuartin, Lidia Mendez, Julio-Cesar Alfaro-Alvarez, Joan Sabater-Riera, Xose L. Perez-Fernandez, Maria Molina-Molina, Salud Santos

Summary: The aim of this study was to assess factors associated with survival, ICU admission, and intubation likelihood in COVID-19 patients admitted to IRCUs. Older age and lack of corticosteroid treatment were associated with higher mortality and intubation risk.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Letter Respiratory System

Hypersensitivity pneumonitis, a differential diagnosis of cystic lung diseases

E. M. Tinoco, G. Bermudo, V. Vicens-Zygmunt, P. Luburich, R. Llatjos, M. Molina-Molina

PULMONOLOGY (2023)

Article Medicine, General & Internal

Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot program

Jaume Bordas-Martinez, Lluis Mateu Gomez, David Camara Menoyo, Marta Lopez-Sanchez, Salud Santos, Maria Molina-Molina, Rosa Planas

Summary: Telemedicine has proven to be a useful tool in telemonitoring and telerehabilitation programs for respiratory patients. This pilot program aims to evaluate the feasibility of a telerehabilitation program for COVID-19 patients from hospital to home. Initial results show that telerehabilitation encourages and empowers patients, with high levels of patient satisfaction.

MEDICINE (2022)

Article Respiratory System

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial

Kevin L. Winthrop, Patrick A. Flume, Rachel Thomson, Kevin C. Mange, Dayton W. Yuen, Monika Ciesielska, Kozo Morimoto, Stephen J. Ruoss, Luigi R. Codecasa, Jae-Joon Yim, Theodore K. Marras, Jakko van Ingen, Richard J. Wallace, Barbara A. Brown-Elliott, Chris Coulter, David E. Griffith

Summary: This study evaluated the safety, tolerability, and efficacy of ALIS combined with GBT in patients with refractory MAC lung disease for 12 months. The results showed that respiratory treatment-emergent adverse events were common, nephrotoxicity and hearing decline were infrequent, and culture conversion continued beyond 6 months of therapy.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Article Respiratory System

Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts

Carlos Machahua, Sabina A. Guler, Michael P. Horn, Lurdes Planas-Cerezales, Ana Montes-Worboys, Thomas K. Geiser, Maria Molina-Molina, Manuela Funke-Chambour

Summary: In this study, it was found that serum calprotectin levels are significantly increased in patients with IPF compared to healthy controls, and are correlated with DLCO and CPI. This suggests that calprotectin may be a potential new biomarker for disease severity in IPF.

BMJ OPEN RESPIRATORY RESEARCH (2021)

Article Respiratory System

Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers

Jessica Germaine Shull, Maria Teresa Pay, Carla Lara Compte, Miriam Olid, Guadalupe Bermudo, Karina Portillo, Jacobo Sellares, Eva Balcells, Vanesa Vicens-Zygmunt, Lurdes Planas-Cerezales, Diana Badenes-Bonet, Rosana Blavia, Pilar Rivera-Ortega, Amalia Moreno, Jordi Sans, Damia Perich, Silvia Barril, Leonardo Esteban, Laia Garcia-Bellmunt, Jordi Esplugas, Guillermo Suarez-Cuartin, Jaume Bordas-Martinez, Diego Castillo, Rosa Jolis, Inma Salvador, Saioa Eizaguirre Anton, Ana Villar, Alejandro Robles-Perez, M. Josefa Cardona, Enric Barbeta, Maria Guadalupe Silveira, Claudia Guevara, Jordi Dorca, Antoni Rosell, Patricio Luburich, Roger Llatjos, Oriol Jorba, Maria Molina-Molina

Summary: This study analyzed the relationship between IPF cases and air pollution concentration in the region of Catalonia, Spain, finding that areas with higher PM2.5 concentrations had a higher prevalence of IPF. Prospect studies with targeted pollution mapping are needed to compile a broader profile of environmental factors involved in the development of pulmonary fibrosis.

RESPIROLOGY (2021)

No Data Available